Further optimization of the M5 NAM MLPCN probe ML375: tactics and challenges

Haruto Kurata, Patrick R Gentry, Masaya Kokubo, Hyekyung P Cho, Thomas M Bridges, Colleen M Niswender, Frank W Byers, Michael R Wood, J Scott Daniels, P Jeffrey Conn, Craig W Lindsley

12 Citations (Scopus)

Abstract

This Letter describes the continued optimization of the MLPCN probe ML375, a highly selective M5 negative allosteric modulator (NAM), through a combination of matrix libraries and iterative parallel synthesis. True to certain allosteric ligands, SAR was shallow, and the matrix library approach highlighted the challenges with M5 NAM SAR within in this chemotype. Once again, enantiospecific activity was noted, and potency at rat and human M5 were improved over ML375, along with slight enhancement in physiochemical properties, certain in vitro DMPK parameters and CNS distribution. Attempts to further enhance pharmacokinetics with deuterium incorporation afforded mixed results, but pretreatment with a pan-P450 inhibitor (1-aminobenzotriazole; ABT) provided increased plasma exposure.

Original languageEnglish
JournalBioorganic & Medicinal Chemistry Letters
Volume25
Issue number3
Pages (from-to)690-4
Number of pages5
ISSN0960-894X
DOIs
Publication statusPublished - 1 Feb 2015
Externally publishedYes

Keywords

  • Allosteric Regulation
  • Animals
  • Brain/metabolism
  • Half-Life
  • Humans
  • Imidazoles/chemistry
  • Indoles/chemistry
  • Microsomes, Liver/metabolism
  • Protein Binding
  • Rats
  • Receptor, Muscarinic M5/chemistry
  • Structure-Activity Relationship

Fingerprint

Dive into the research topics of 'Further optimization of the M5 NAM MLPCN probe ML375: tactics and challenges'. Together they form a unique fingerprint.

Cite this